← Back to Clinical Trials
Recruiting NCT03142022

Sleep-disordered Breathing After Solid Organ Transplantation

Trial Parameters

Condition Lung Transplantation
Sponsor Universitaire Ziekenhuizen KU Leuven
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2014-11
Completion 2025-12
Interventions
No intervention - Diagnostic polysomnography at 1 year after lung transplantation

Brief Summary

Sleep-disordered breathing (SDB) describes a group of disorders in which partial or complete cessation of breathing occurs many times throughout the night, resulting in daytime sleepiness or fatigue that interferes with a person's ability to function and reduces quality of life. Transplantation has become an important treatment modality for end-stage organ failure. Transplant recipients are now living longer and, hence, develop chronic adverse medical conditions. Furthermore, transplantation is associated with weight gain. Despite the high prevalence of poor sleep and cardiovascular conditions among transplant patients, SDB is not well studied in these patients.

Eligibility Criteria

Inclusion Criteria: * Patients 1 year after lung transplantation Exclusion Criteria: * Refusal of PSG * Medical contra-indication to perform PSG

Related Trials